Panic disorder patients have reduced cyclic AMP in platelets

Journal of Psychiatric Research

Volumn 36, Issue 2, 2002, Pages 105-110

  Marcourakis, Tania ^a   Gorenstein, Clarice ^a   Brandão De Almeida Prado, Euthymia ^a   Teodoro Ramos, Renato ^a   Glezer, Isaias ^a   Sena Bernardes, Cristiane ^a   Mitiko Kawamoto, Elisa ^a   Scavone, Cristoforo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clomipramine; Cyclic AMP; Cyclic GMP; Nitric oxide; Panic disorder; Platelets

Indexed keywords

CLOMIPRAMINE; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE SYNTHASE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PANIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RATING SCALE; SECOND MESSENGER; THROMBOCYTE;

EID: 0036134133     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00053-X     Document Type: Article

References (31)

1. Diagnostic and statistical manual of mental disorders
2. Assessing the efficacy of treatment for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale
3. The use of the Panic and Agoraphobia Scale (P&A) in a controlled clinical trial
4. An inventory for measuring depression
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme
7. Comparative effects of low and high doses of clomipramine and placebo in panic disorder; a double-blind controlled study. French University Antidepressant Group
8. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders; effects of diagnosis, suicide, and treatment at the time of death
9. A molecular and cellular theory of depression
10. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder
11. Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with impramine
12. 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome
13. ECDEU assessment manual for psychopharmacology, revised. DHEW Publication no. ADM 76-338
14. The assessment of anxiety states by rating
15. A rating scale for depression
16. Mental disorders in primary health care: a study of their frequency and diagnosis in four developing countries
17. Initiation and adaptation; a paradigm for understanding psychotropic drug action
18. A dose-finding and discontinuation study of clomipramine in panic disorder
19. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder
20. Platelet's nitric oxide synthase activity in Alzheimer's disease patients
21. Nitric oxide, cyclic GMP, and hormone regulation of active sodium transport
22. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex
23. Altered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorder
24. Altered rap1 endogenous phosphorilation and levels in platelets from patients with bipolar disorder
25. The platelet intracellur calcium response to serotonin and thrombin in patients with panic disorder
26. The anxiety disease
27. Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers
28. Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients
29. Protein phosphorylation and neuronal function
30. Cyclic GMP-dependent protein kinase substrates in rat brain
31. SCAN; schedules for clinical assessment in neuropsychiatry